Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preserved versus unpreserved low-dose atropine for ocular surface effects
ACTRN12617000571370Phase 4Recruiting
- Sponsor
- University of New South Wales
- Start
- Aug 2017
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of atropine in myopia (2 arms), sponsored by University of New South Wales. Primary endpoint: Change in non-invasive tear breakup time. Started Aug 2017; status: recruiting.
02
Drugs
atropine
03
Conditions
myopia
Beyond the preview
Go deeper on ACTRN12617000571370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617000571370.